Fibrinogen to Albumin Ratio as an Independent Risk Factor for Type 2 Diabetic Kidney Disease. 2021

Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, People's Republic of China.

OBJECTIVE Diabetic kidney disease (DKD) is an inflammatory disease. This study aimed to investigate the association of fibrinogen to albumin ratio (FAR) with DKD. METHODS A total of 1022 type 2 diabetes mellitus (T2DM) patients with DKD and 1203 T2DM patients without DKD were enrolled in this study. Laboratory values including blood cell count, hemoglobin A1c, biochemical parameters, and fibrinogen and albumin creatinine ratio were recorded. Patients were classified according to tertile of admission FAR. Clinical parameters were compared between groups. Logistic regression, linear regression, ROC analysis and spline regression were carried out. RESULTS FAR in the DKD group was significantly higher than that in the non-DKD group. FAR had the highest odds ratio as an independent risk factor for the development of DKD and the highest area under ROC curve for predicting DKD compared with albumin (ALB) or fibrinogen (FIB) alone. Simple linear regression analyses revealed a significant and linear correlation of FAR with neutrophil and neutrophil-to-lymphocyte ratio. FAR was an independent risk factor for development of DKD. Spline regression showed that there was a significant linear association between DKD incidence and continuous FAR value when it exceeded 67.3mg/g. CONCLUSIONS FAR is a stronger independent predictor of DKD than FIB and ALB. FAR is an independent risk factor for DKD development when it exceeded 67.3mg/g. FAR might be one of novel diagnostic biomarkers to predict and prevent DKD progression. However, a prospective study to validate the prognostic model is still needed.

UI MeSH Term Description Entries

Related Publications

Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
September 2022, The Journal of clinical endocrinology and metabolism,
Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
May 2022, Geriatrics & gerontology international,
Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
January 2022, Diabetes, metabolic syndrome and obesity : targets and therapy,
Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
August 1992, Lakartidningen,
Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
June 2021, Scientific reports,
Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
January 2005, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation,
Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
May 2001, Medicina clinica,
Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
January 1998, Indian heart journal,
Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
June 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD,
Kai Wang, and Wenjun Xu, and Bingbing Zha, and Jindong Shi, and Guowei Wu, and Heyuan Ding
January 2022, Frontiers in endocrinology,
Copied contents to your clipboard!